Cargando…
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
OBJECTIVE: Cannabinoid-based medications provide not only relief for specific symptoms, but also arrest or delay of disease progression in patients with pain, multiple sclerosis, and other conditions. Although they also seem to hold potential as anticonvulsant agents, evidence of their efficacy in e...
Autor principal: | Capasso, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/ https://www.ncbi.nlm.nih.gov/pubmed/29290836 http://dx.doi.org/10.2174/1874205X01711010061 |
Ejemplares similares
-
Cannabinoid Conference 2022
Publicado: (2022) -
Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases
por: Rapino, Cinzia, et al.
Publicado: (2018) -
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
por: Perucca, Emilio
Publicado: (2017) -
Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
por: Morano, Alessandra, et al.
Publicado: (2020) -
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
por: Kwan Cheung, Keith A., et al.
Publicado: (2019)